Effects of the progestagen‐only contraceptive implant Implanon® on cardiovascular risk factors
- 20 August 2007
- journal article
- research article
- Published by Wiley in Clinical Endocrinology
- Vol. 68 (3), 355-360
- https://doi.org/10.1111/j.1365-2265.2007.03046.x
Abstract
Objective: Epidemiological studies on the cardiovascular risk of progestagen-only contraceptives are rare. With the present study we aimed to investigate the effect of the low-dose etonogestrel-releasing contraceptive implant Implanon® on cardiovascular risk factors, including markers of inflammation.\ud \ud Design: Longitudinal study.\ud \ud Setting: Family planning centre of a University Hospital.\ud \ud Subjects: Thirty-six healthy, nonsmoking women with regular cycles (n = 18 controls without hormonal contraception; n = 18 cases requesting the insertion of Implanon®).\ud \ud Measurements: Blood samples for the determination of C-reactive protein (CRP), nitric oxide (NO), sex hormones and plasma lipids were taken in the early follicular phase of the cycle in both groups. A second sample was taken 12 weeks after Implanon insertion or in the controls during the early follicular phase of cycle 4.\ud \ud Results: Implanon treatment caused a 36% decrease in CRP (P < 0·06) and a significant decrease in high density lipoprotein (HDL) (P < 0·007), low density lipoprotein (LDL) (P < 0·001), cholesterol (P < 0·001), testosterone (P < 0·05) and SHBG (P < 0·002). Levels of NO, oestradiol and progesterone were not affected in either group. The cholesterol/HDL ratio did not change in Implanon carriers. There was a significant correlation between the cardiovascular risk factors CRP, cholesterol/HDL ratio and NO.\ud \ud Conclusion: The progestagen-only implant Implanon does not exert a negative effect on the cardiovascular risk factors CRP, cholesterol/HDL ratio and NO. These results suggest that the use of a progestagen-only contraception does not increase cardiovascular risk factors in healthy young womenKeywords
This publication has 52 references indexed in Scilit:
- Effects of synthetic progestagens on autonomic tone, neurohormones and C-reactive protein levels in young healthy females in reproductive ageInternational Journal of Cardiology, 2006
- Global inflammation predicts cardiovascular risk in women: A report from the Women's Ischemia Syndrome Evaluation (WISE) studyAmerican Heart Journal, 2005
- Hormone therapy, C-reactive protein, and progression of atherosclerosis: Data from the Estrogen Replacement on Progression of Coronary Artery Atherosclerosis (ERA) trialAmerican Heart Journal, 2005
- Distribution and determinants of serum high‐sensitive C‐reactive protein in a population of young adults. The Cardiovascular Risk in Young Finns StudyJournal of Internal Medicine, 2005
- Inflammatory Markers and the Risk of Coronary Heart Disease in Men and WomenThe New England Journal of Medicine, 2004
- Sex hormone–binding globulin—A surrogate marker for the prothrombotic effects of combined oral contraceptivesAmerican Journal of Obstetrics and Gynecology, 2004
- Hormone Replacement Therapy and InflammationHypertension, 2003
- Endothelial nitric oxide in humans in health and diseaseInternational Journal of Experimental Pathology, 1999
- Ovarian Function During the Use of a Single Contraceptive Implant: Implanon Compared with NorplantFertility and Sterility, 1998
- Circulating Nitrite/Nitrate Levels Increase with Follicular Development: Indirect Evidence for Estradiol-Mediated NO ReleaseBiochemical and Biophysical Research Communications, 1994